IMPORTANT SAFETY INFORMATION and INDICATION for ABILIFY:
U.S. FULL PRESCRIBING INFORMATION, including Boxed WARNINGS, and Medication Guide.

Antidepressants may increase suicidal thoughts or behaviors in some children, teenagers, and young adults, especially within the first few months of treatment or when the dose is changed. Depression and other serious mental illnesses are themselves associated with an increase in the risk of suicide. Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, unusual changes in behavior, or thoughts of suicide. Such symptoms should be reported to the patient's healthcare provider right away, especially if they are severe or occur suddenly. ABILIFY®(aripiprazole) is not approved for use in pediatric patients with depression. See More Safety Information

INDICATION: ABILIFY (aripiprazole) is indicated for the treatment of irritability associated with autistic disorder in pediatric patients 6 to 17 years of age, as part of a total treatment plan.

Family Support

Caring for a child who has irritability associated with autistic disorder can be difficult and isolating, but there are steps you can take to help.

If your child’s behavior limits community involvement, disrupts family life, or threatens his or her safety, talk to a doctor about treatment options. It may help to write down your concerns before your visit. Here are the types of issues you may want to bring up:

  • Troubling behaviors. Mention specific behaviors, not your interpretation of them (for example, “pacing and screaming” instead of “agitated”)
  • Changes over time. Has your child always behaved like this? If not, when did it start?
  • Occurrences. In what situations are the problem behaviors most and least likely to happen?
family support

Community Resources

Here are some organizations that provide support for parents of children with autistic disorder:


The organizations and resources listed are not affiliated with Otsuka America Pharmaceutical, Inc. As such, Otsuka America Pharmaceutical, Inc. does not adopt, endorse, opine, or make any representation as to the truth, accuracy, legality, or any other aspect of the information provided by these organizations or resources.

Important Safety Information: Increases in blood sugar levels (hyperglycemia) can happen in some people who take ABILIFY (aripiprazole). Extremely high blood sugar can lead to coma or death. If you have diabetes, or risk factors (for example, obesity, family history of diabetes), or have the following symptoms: increases in thirst, urination, or hunger, feel weak or tired, sick to your stomach, or confused (or breath smells fruity), your blood sugar should be monitored.

See More Safety Information